kabutan

DAIKEN MEDICAL, First Half Ordinary Profit Decreases by 19%

Fri Oct 31, 2025 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD <7775> [TSE Std] announced its financial results after the market closed on October 31st (16:00). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2026 (April to September) decreased 19.4% from the same period last year to 0.67 billion yen. However, Progress toward the full-year plan of 1.00 billion yen was 67.4%, also surpassing the five-year average of 52.9%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to significant drop 51.6% from the same period last year to 0.32 billion yen.

In the most recent three-month period, from July to September (2Q), the ordinary profit decreased to 0.39 billion yen, a 10.5% decrease compared to the same period last year. The operating profit margin decreased from 17.4% in the same period last year to 15.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 4,824 745 750 537 18.7 51.7 Oct 31, 2023 J-GAAP
Apr - Sep, 2024 4,914 836 836 608 21.2 55.4 Oct 31, 2024 J-GAAP
Apr - Sep, 2025 5,057 676 674 511 17.8 67.4 Oct 31, 2025 J-GAAP
YoY +2.9% -19.1% -19.4% -16.0% -15.9%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance 5,120 460 455 320 11.1 9 May 15, 2025 J-GAAP
Apr - Sep, 2025 Results 5,057 676 674 511 17.8 9 Oct 31, 2025 J-GAAP
Revision Rate -1.2% +47.0% +48.1% +59.7% +60.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 5,037 676 674 489 17.0 14 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 5,443 334 326 189 6.6 11 Oct 31, 2025 J-GAAP
YoY +8.1% -50.6% -51.6% -61.3% -61.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 9,951 1,512 1,510 1,097 38.2 23 May 15, 2025 J-GAAP
Mar, 2026 Guidance 10,500 1,010 1,000 700 24.4 20 May 15, 2025 J-GAAP
YoY +5.5% -33.2% -33.8% -36.2% -36.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 2,519 439 438 319 11.1 17.4 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 2,751 479 479 349 12.2 17.4 Jan 31, 2025 J-GAAP
Jan - Mar, 2025 2,286 197 195 140 4.9 8.6 May 15, 2025 J-GAAP
Apr - Jun, 2025 2,497 281 282 215 7.5 11.3 Jul 31, 2025 J-GAAP
Jul - Sep, 2025 2,560 395 392 296 10.3 15.4 Oct 31, 2025 J-GAAP
YoY +1.6% -10.0% -10.5% -7.2% -7.2%

Related Articles